Business Description
Founded in 2009 and based in Suzhou, China, Ascentage Pharma is a clinical-stage biopharmaceutical company focused on developing treatments for cancer, chronic hepatitis B, and age-related conditions. The company has built a pipeline of investigational drugs designed to restore or trigger natural cell death in diseased cells, targeting a range of blood cancers, solid tumors, and viral infections. Ascentage works alongside research institutions and industry partners to advance its programs through clinical trials, and its activities extend to technology services and venture investment.
